Possible drawbacks of relying only on molecular testing for diagnosing SARS-CoV-2 infections.
作者信息
Lippi G, Henry B M
机构信息
Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
出版信息
Public Health. 2022 Apr;205:e2. doi: 10.1016/j.puhe.2021.09.035. Epub 2021 Oct 5.
Abstract
摘要
相似文献
1
Possible drawbacks of relying only on molecular testing for diagnosing SARS-CoV-2 infections.仅依靠分子检测诊断新冠病毒感染的潜在弊端。
Public Health. 2022 Apr;205:e2. doi: 10.1016/j.puhe.2021.09.035. Epub 2021 Oct 5.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益（CoV-Surv 研究）：一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
Hospital laboratory experience with SARS-CoV-2 (COVID-19) molecular assay sample pooling method in New York City.纽约市医院实验室采用严重急性呼吸综合征冠状病毒2（新冠病毒病）分子检测样本合并方法的经验。
J Clin Pathol. 2022 Jan;75(1):65-67. doi: 10.1136/jclinpath-2020-207077. Epub 2021 Feb 15.
4
Could mutations of SARS-CoV-2 suppress diagnostic detection?新型冠状病毒（SARS-CoV-2）的突变会影响诊断检测吗？
Nat Biotechnol. 2021 Mar;39(3):274-275. doi: 10.1038/s41587-021-00845-3.
5
Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA.比较九种不同市售的用于检测 SARS-CoV-2 RNA 的分子检测方法。
Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1303-1308. doi: 10.1007/s10096-021-04159-9. Epub 2021 Jan 29.
6
Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: Toward the future prospects.利用潜在的即时检测电化学免疫传感器快速诊断 SARS-CoV-2：展望未来。
Int Rev Immunol. 2021;40(1-2):126-142. doi: 10.1080/08830185.2021.1872566. Epub 2021 Jan 15.
7
Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test Results.实验室生成的 DNA 可能导致异常的病原体诊断测试结果。
Microbiol Spectr. 2021 Oct 31;9(2):e0031321. doi: 10.1128/Spectrum.00313-21. Epub 2021 Sep 15.
8
Comparative Performance of a New SARS-CoV-2 Rapid Detection System.新型 SARS-CoV-2 快速检测系统的比较性能。
Microbiol Spectr. 2021 Oct 31;9(2):e0020521. doi: 10.1128/Spectrum.00205-21. Epub 2021 Oct 13.
9
At-home coronavirus testing: the next game-changer?居家新冠病毒检测：下一个改变游戏规则的事物？
Expert Rev Mol Diagn. 2021 Jan;21(1):1-2. doi: 10.1080/14737159.2021.1873133. Epub 2021 Jan 11.
10
Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.基于唾液检测诊断新型冠状病毒2019感染：一项荟萃分析。
J Med Virol. 2021 Mar;93(3):1256-1258. doi: 10.1002/jmv.26613. Epub 2020 Nov 10.
引用本文的文献
1
Comparison between N-803 and Erdafitinib in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer.N-803与厄达替尼在卡介苗无反应性非肌肉浸润性膀胱癌中的比较
Cancers (Basel). 2024 Oct 11;16(20):3445. doi: 10.3390/cancers16203445.
2
Evaluation of a new molecular test for the detection of SARS-CoV-2 nucleic acid in salivary samples.评估一种用于检测唾液样本中SARS-CoV-2核酸的新型分子检测方法。
J Med Biochem. 2023 Oct 27;42(4):658-664. doi: 10.5937/jomb0-43822.
本文引用的文献
1
Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.2021 年 5 月至 6 月期间中国广东地区 SARS-CoV-2 Delta 变异株感染的传播动态和流行病学特征。
Euro Surveill. 2022 Mar;27(10). doi: 10.2807/1560-7917.ES.2022.27.10.2100815.
2
Do members of the public think they should use lateral flow tests (LFT) or polymerase chain reaction (PCR) tests when they have COVID-19-like symptoms? The COVID-19 Rapid Survey of Adherence to Interventions and Responses study.公众在出现类似 COVID-19 症状时，认为他们应该使用侧向流动检测（LFT）还是聚合酶链反应（PCR）检测？COVID-19 快速干预措施依从性和反应调查研究。
Public Health. 2021 Sep;198:260-262. doi: 10.1016/j.puhe.2021.07.023. Epub 2021 Jul 28.
3
Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.新型 SARS-CoV-2 抗原快速诊断准确性的系统评价和荟萃分析。
PLoS Med. 2021 Aug 12;18(8):e1003735. doi: 10.1371/journal.pmed.1003735. eCollection 2021 Aug.
4
Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019.基于细胞的培养可用于告知 2019 冠状病毒病患者的传染性和安全解除隔离评估。
Clin Infect Dis. 2021 Nov 2;73(9):e2952-e2959. doi: 10.1093/cid/ciaa1579.
Zotero 插件